AOXING PHARMACEUTICAL COMPANY, INC. Earnings Per Share (Diluted)
AOXING PHARMACEUTICAL COMPANY, INC. reported Earnings Per Share (Diluted) of $0.01 per share for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2017-05-15
- AOXING PHARMACEUTICAL COMPANY, INC. earnings per share, diluted for the quarter ending 2017-03-31 was $0.00, a 82.66% decline year-over-year.
- AOXING PHARMACEUTICAL COMPANY, INC. earnings per share, diluted for the quarter ending 2016-12-31 was -$0.00, a 101.90% decline year-over-year.
- AOXING PHARMACEUTICAL COMPANY, INC. earnings per share, diluted for the quarter ending 2016-06-30 was -$0.02, a 138.38% decline year-over-year.
- AOXING PHARMACEUTICAL COMPANY, INC. earnings per share, diluted for the quarter ending 2016-03-31 was $0.01, a 0.00% change year-over-year.
- AOXING PHARMACEUTICAL COMPANY, INC. earnings per share, diluted for fiscal 2016 was $0.03, a 66.67% decline from fiscal 2015.
- AOXING PHARMACEUTICAL COMPANY, INC. earnings per share, diluted for fiscal 2015 was $0.09.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2017-03-31 | $0.00 derived: net income ÷ weighted average shares · filed 2017-05-15 | $0.00 derived: net income ÷ weighted average shares · filed 2017-05-15 | $0.01 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-17 | $0.00 derived: net income ÷ weighted average shares · filed 2017-02-17 | ||
| 2016-06-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2016-10-05 | -$0.02 derived: net income ÷ weighted average shares · filed 2017-05-15 | $0.01 derived: net income ÷ weighted average shares · filed 2017-05-15 | $0.03 10-K · filed 2016-10-05 |
| 2016-03-31 | $0.01 10-Q · filed 2017-05-15 | $0.04 derived: net income ÷ weighted average shares · filed 2017-05-15 | $0.05 10-Q · filed 2017-05-15 | |
| 2015-12-31 | $0.03 10-Q · filed 2017-02-17 | $0.05 10-Q · filed 2017-02-17 | ||
| 2015-06-30 | $0.06 derived: net income ÷ weighted average shares · filed 2016-10-05 | $0.07 derived: net income ÷ weighted average shares · filed 2016-10-05 | $0.09 derived: net income ÷ weighted average shares · filed 2016-10-05 | $0.09 10-K · filed 2016-10-05 |
| 2015-03-31 | $0.01 10-Q · filed 2016-05-16 | $0.02 derived: net income ÷ weighted average shares · filed 2016-05-16 | $0.02 10-Q · filed 2016-05-16 | |
| 2014-12-31 | $0.01 10-Q · filed 2016-02-08 | $0.01 10-Q · filed 2016-02-08 | ||
| 2011-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2013-02-14 | -$0.03 derived: net income ÷ weighted average shares · filed 2013-02-14 | ||
| 2011-09-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2013-02-08 | |||
| 2010-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2012-09-28 | -$0.02 derived: net income ÷ weighted average shares · filed 2012-09-28 | ||
| 2010-09-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2012-09-28 |